BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

SFL's Managing Director Invited to Speak at Regulatory Affairs Professionals Society Meeting in Lausanne


5/29/2013 10:24:05 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

May 29, 2013 -- SFL is pleased to announce that Shayesteh Fürst-Ladani, SFL’s Managing Director, has been invited to give a presentation entitled “Early consideration of market access aspects – Impact on regulatory strategy” on 30 May 2013 at the Market Access Preliminary Skills for Regulatory Professionals event organized by the Regulatory Affairs Professionals Society (RAPS) Switzerland Chapter in Lausanne.

New evidence-based healthcare policies and budget controls are heightening interest in the emerging area of market access and health technology assessment (HTA). RAPS Switzerland has therefore been developing a Market Access Preliminary Skills for Regulatory Professionals’ Center of Excellence where participants can learn from industry specialists.

Shayesteh commented “I will outline the approach required to ensure that elements of common interest to both regulators and HTA bodies can be incorporated into companies’ clinical development plans.”

Shayesteh is the Managing Director and founder of SFL. She has comprehensive experience in formulating global regulatory strategies and provides support for the development of drugs, orphan drugs, drug and device combination products, borderline products, medical devices, in vitro diagnostics and advanced therapy medicinal products. Shayesteh is Chair of the Combination Products Topic Group at EuropaBio. She has been member of the Program Committee of DIA EuroMeeting for 2011, 2012, 2013 and 2014 leading the Theme Drugs, Devices, In Vitro Diagnostics and their Combinations. In 2012 she received the Open University Business School’s Alumni Award Outstanding Contribution to an Organization.



Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES